default author photo

Juan Manuel Sancho

Hospital Germans Trias y Pujol (ICO-IJC) - Hematology Department

Badalona

Spain

SCHOLARLY PAPERS

2

DOWNLOADS

176

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Selinexor in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (SADAL): A Single-Arm Multinational Phase 2 Trial

Number of pages: 196 Posted: 11 Feb 2020
University of Liverpool, Université Libre de Bruxelles (ULB) - Institute Jules Bordet, University of Turin, NHS Foundation Trust - Addenbrooke's Hospital, Hackensack University - Hackensack University Medical Center, Leiden University - Leiden University Medical Center (LUMC), Centre Hospitalier Universitaire (CHU) de Bordeaux - Clinical Hematology Service, St. Vincent's Hospital Sydney, VU University Amsterdam - Department of Hematology, Dr. B. R. A. Institute Rotary Cancer Hospital AIIMS, Aix-Marseille University - Institut Paoli-Calmettes, Sorbonne University - University Hospitals Pitié Salpêtrière - Charles Foix, Tel Aviv University - Rabin Medical Center, Cleveland Clinic - Department of Hematology & Medical Oncology, Medical University of Vienna, Hospital Germans Trias y Pujol (ICO-IJC) - Hematology Department, State University of New York (SUNY), Stony Brook, University of Paris, Virgen del Rocio University, Kaposi MorCounty Teaching Hospital, Institute of Medical Sciences & SUM Hospital, Ghent University - Ghent University Hospital, National and Kapodistrian University of Athens, Instytut Hematologii i Transfuzjologii, Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Karyopharm Therapeutics, Inc., Catholic University of Louvain (UCL) - Cliniques Universitaires Saint-Luc and Hospital Universitario La Paz
Downloads 110 (640,165)

Abstract:

Loading...

Selinexor, SADAL trial, Relapsed/Refractory, Diffuse Large B-cell Lymphoma

2.

Life Expectancy of Follicular Lymphoma Patients in Complete Response at 30 Months is Similar to that of the Spanish General Population

Number of pages: 30 Posted: 24 Sep 2018
Hospital Clinic of Barcelona, Hospital Universitario de Salamanca, Hospital Universitario de Salamanca, Hospital Clinic of Barcelona, Hospital Universitario Mutua de Terrassa, University of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Hospital Clinic of Barcelona, Miguel Servet University Hospital - Hematology Department, Miguel Servet University Hospital - Hematology Department, Hospital General Virgen del Rocío, Hospital Germans Trias y Pujol (ICO-IJC) - Hematology Department, Hospital Germans Trias y Pujol (ICO-IJC) - Hematology Department, Hospital Duran i Reynals (ICO) - Hematology Department, Hospital Duran i Reynals (ICO) - Hematology Department, Autonomous University of Barcelona - Health Services Research Unit, Autonomous University of Barcelona - Health Services Research Unit, Hospital de la Princesa - Hematology Department, Hospital de la Princesa - Hematology Department, Hospital Clínico de Valencia, Hospital Clínico de Valencia, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Hospital Marqués de Valdecilla, Hospital de Nuestra Señora de la Esperanza - Hematology Department, Hospital MD Anderson - Hematology Department, Hospital Sant Pau - Hematology Department, Hospital del Bierzo - Hematology Department, Hospital infanta Leonor - Hematology Department, Hospital Virgen del Puerto - Hematology Department, Universidad Autónoma de Madrid - IIS-Fundación Jiménez Díaz, Hospital Universitario de Salamanca, Hospital Universitario de Salamanca, Hospital Universitario de Salamanca and Hospital Clinic of Barcelona
Downloads 66 (907,769)

Abstract:

Loading...

Follicular lymphoma, complete response, survival